Ke. Aldridge, THE OCCURRENCE, VIRULENCE, AND ANTIMICROBIAL RESISTANCE OF ANAEROBES IN POLYMICROBIAL INFECTIONS, The American journal of surgery, 169(5A), 1995, pp. 2-7
Polymicrobial aerobic/anaerobic bacterial infections occur frequently
and have been documented in most anatomic sites in the body. The etiol
ogy of these infections is endogenous in that the normal microbial flo
ra that colonize the various mucosal surfaces of the body can be isola
ted from these infections after trauma to these membranes allowing the
se organisms access to normally sterile sites. Subsequently, the organ
isms begin to proliferate, causing extensive tissue damage. These infe
ctions may spread to adjacent tissues or become loculated with abscess
formation. In patients judged to have severe infection, surgery is of
ten needed to debride the advancing spread of the infection, remove lo
culated pus, and reestablish sufficient blood flow to deliver appropri
ate antimicrobial agents to the infected site. Choice of antimicrobial
agents should include agents with activity against both aerobes and a
naerobes. Although a variety of anaerobes can be isolated from these i
nfections, the Bacteroides fragilis group is the most clinically impor
tant group of anaerobes because of the production of virulence factors
and the high incidence of beta-lactamase production. Against the vari
ous B. fragilis group species, metronidazole remains a very active age
nt, whereas resistance rates to clindamycin are high among the non-B.
fragilis species. Because of the good activity of many cephalosporin/c
ephamycin agents against aerobic gram-negative bacteria and moderate t
o good activity against anaerobes, these compounds remain as broad-spe
ctrum choices for use in therapy of mixed infections. The addition of
beta-lactamase inhibitors (tazobactam, sulbactam, or clavulanate) to v
arious beta-lactam agents has increased their antimicrobial spectrum a
gainst certain groups of aerobes, and particularly against beta-lactam
ase-producing anaerobes, including the B. fragilis group. The choice o
f single-agent therapy of mixed infections is ideally based on local d
ata of susceptibility patterns of the various aerobes and anaerobes in
volved in these infections.